TTI fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Thiogenesis Therapeutics Corp. engages in developing novel drug formulations that act as precursors for rare diseases. The company was founded in 2018 and is headquartered in Toronto, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
TTI has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company